Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Neuro-Oncology Practice|April 26, 2018
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluationKatrina A Morris, John F Golding, Patrick R Axon, et al.The Lancet. Neurology|February 21, 2006
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up studyTijmen Korteweg, Mar Tintoré, Bernard Uitdehaag, et al.Journal of Neuro-Oncology|November 1, 2016
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohortKatrina A Morris, John F Golding, Claire Blesing, et al.Archives of Disease in Childhood|March 15, 2018
Diagnosis of sporadic neurofibromatosis type 2 in the paediatric populationGeetha Anand, Grace Vasallo, Maria Spanou, et al.BMC Psychiatry|August 14, 2020
Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and womenSusan Young, Nicoletta Adamo, Bryndís Björk Ásgeirsdóttir, et al.World Journal of Psychiatry|April 10, 2023
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statementSusan Young, Cyrus Abbasian, Zainab Al-Attar, et al.BMC Psychiatry|February 5, 2021
Recommendations for occupational therapy interventions for adults with ADHD: a consensus statement from the UK adult ADHD networkMarios Adamou, Philip Asherson, Muhammad Arif, et al.Journal of Medical Genetics|August 16, 2015
Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patientsAdam Hexter, Adrian Jones, Harry Joe, et al.Frontiers in Psychiatry|April 5, 2021
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus StatementSusan Young, Philip Asherson, Tony Lloyd, et al.Neurosurgery|October 4, 2017
Malignant Peripheral Nerve Sheath Tumors are not a Feature of Neurofibromatosis Type 2 in the Unirradiated PatientAndrew T King, Scott A Rutherford, Charlotte Hammerbeck-Ward, et al.Pageof 4